Status:
NO_LONGER_AVAILABLE
Defibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the Liver
Lead Sponsor:
Emory University
Conditions:
Liver Diseases
Eligibility:
All Genders
1-22 years
Brief Summary
Severe veno-occlusive disease (VOD) of the liver is a life threatening complication of blood and marrow transplantation. Treatment with currently available (Food and Drug Administration \[FDA\] approv...
Detailed Description
Severe veno-occlusive disease (VOD) of the liver is a life threatening complication of blood and marrow transplantation. Treatment with currently available (FDA approved) agents fails in most cases. R...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Veno-occlusive disease of the liver
Exclusion
Key Trial Info
Start Date :
November 1 2005
Trial Type :
EXPANDED_ACCESS
End Date :
June 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00263978
Start Date
November 1 2005
End Date
June 1 2009
Last Update
July 1 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322